Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXb20020605	拉米夫定片	lamivudine	Tablet	Chemical Drugs(1)	Supplementary Application	2002-09-10	葛兰素史克制药（苏州）有限公司	Glaxosmithkline Pharmaceuticals (Suzhou) Co Ltd	Approval Completed-Pending Certificated	2003-01-09	view
CYHB0600776	注射用头孢呋辛钠	cefuroxime sodium	Lyophilized	Chemical Drugs	Supplementary Application	2006-04-30	葛兰素史克制药（苏州）有限公司	Glaxosmithkline Pharmaceuticals (Suzhou) Co Ltd	Certificate Issued	2007-02-01	view
CYHB1404379	拉米夫定片	lamivudine	Tablet	Chemical Drugs	Supplementary Application	2014-08-14	葛兰素史克制药（苏州）有限公司	Glaxosmithkline Pharmaceuticals (Suzhou) Co Ltd	Certificate Issued	2015-05-04	view
CYHB1704260	拉米夫定片	lamivudine	Tablet	Chemical Drugs	Supplementary Application	2017-09-18	葛兰素史克制药（苏州）有限公司	Glaxosmithkline Pharmaceuticals (Suzhou) Co Ltd	Certificate Issued	2018-02-24	view